Long COVID in children is no fringe oddity; some clinicians now compare its frequency to asthma. That claim rests on cohorts showing persistent fatigue, headaches, sleep disruption and cognitive complaints in a notable slice of infected children, sometimes months after a mild or even silent acute infection.
What unsettles pediatric specialists is not only how often it appears but how differently it wears each age. In younger children, long COVID clinics report more gastrointestinal pain, dysautonomia symptoms such as dizziness, and behavioral shifts, patterns that hint at immune dysregulation in developing mucosal immunity and the autonomic nervous system.
By contrast, adolescents more often present with exercise intolerance, post‑exertional malaise, and shortness of breath that can resemble classic asthma yet may arise from endothelial dysfunction or persistent inflammation in the microvasculature rather than bronchial hyperreactivity alone. That overlap complicates spirometry results, diagnosis and treatment choices for already stretched pediatric services.
Behind these age‑specific patterns lies a blunt lesson: a maturing immune system reshapes the aftershocks of SARS‑CoV‑2. Shifts in T‑cell repertoire, antibody affinity maturation and cytokine signaling appear to decide whether a child shrugs off infection or enters months of multisystem symptoms that do not fit neatly into older respiratory disease labels.
